3652 results for «331»
3652 results
Is frailty still relevant after 20 years of TAVI?
28 Nov 2022 – From PCR London Valves 2022
Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.
Imaging for mitral valve interventions
28 Nov 2022 – From PCR London Valves 2022
Thanks to this PCR LV 2022 session, find out more about outcome of patients undergoing transcatheter edge-to-edge mitral valve repair with HFpEF diagnosis.
Valve-in-valve TAVI: Session 2
28 Nov 2022 – From PCR London Valves 2022
Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...
TAVI in complex situations - LIVE case
28 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI with the presence of a mechanical mitral valve.
An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
TAVI in patients at risk of coronary occlusion
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI in patients at risk of coronary occlusion to discover a selection of cases presented during PCR LV 2022: hyperacute obstruction of the left main artery due to calcium displacement during TAVR, cannulation technique for challenging coronary access following TAVI-in-TAVI, complex TAVI from...
Challenging scenarios: TAV-in-TAV procedures
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover some challenging TAV-in-TAV procedures, and learn more about the key role of imaging during pre-procedural work-up and the potential treatment options after TAVI bioprosthetic valve fracture.
Mitral: new devices and procedural refinements
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of cases regarding mitral new devices: transapical mitral valve implantation for treatment of symptomatic mitral valve disease, transcatheter edge-to-edge mitral valve repair for atrial functional mitral regurgitation, and much more!
Secondary mitral regurgitation: challenges in management
28 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions
08 Sep 2024
Mirvat Alasnag provides her take on REC-CAGEFREE I, a multicenter, non-inferiority trial presented at the ESC Congress 2024 in London.
Author
UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial
19 Sep 2022
Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
